Related Experiment Video
Updated: Jun 22, 2026

07:45
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity?
C Wider1, J A Van Gerpen, S DeArmond
1Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA.
Neurology
|June 3, 2009
Summary
Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) and familial pigmentary orthochromatic leukodystrophy (POLD) may be the same adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). This finding reclassifies these distinct neurological disorders.
Area of Science:
- Neurology
- Neuroscience
- Genetics
Background:
- Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) and familial pigmentary orthochromatic leukodystrophy (POLD) are considered distinct adult-onset neurodegenerative diseases.
- Both conditions manifest with dementia, motor deficits, and epilepsy.
Purpose of the Study:
- To review existing literature and evaluate the evidence supporting the unification of HDLS and POLD into a single disease entity.
- To propose a new collective classification for these related leukoencephalopathies.
Main Methods:
- Comprehensive literature review of studies on HDLS and POLD.
- Comparative analysis of clinical presentations, pathological hallmarks, and genetic data.
Main Results:
- Familial POLD shares significant clinical similarities with HDLS, including dementia, motor impairment, and epilepsy.
- Pathological findings, such as axonal spheroids (HDLS) and pigmented macrophages (POLD), are present in both conditions.
- Slight differences in age of onset, disease progression, and neurological involvement were noted but do not warrant separate classification.
Conclusions:
- HDLS and POLD represent a single disease entity, not distinct conditions.
- The collective term adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is proposed to encompass both previously separate diagnoses.
- This reclassification aids in understanding and potentially treating these rare neurological disorders.
Related Concept Videos
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Genetic Lingo
Overview
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

